Savara Inc. Announces Material Agreement and Executive Changes
Ticker: SVRA · Form: 8-K · Filed: Apr 12, 2024 · CIK: 1160308
| Field | Detail |
|---|---|
| Company | Savara Inc (SVRA) |
| Form Type | 8-K |
| Filed Date | Apr 12, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, executive-changes, board-changes
TL;DR
Savara Inc. inked a new deal and shuffled execs/directors on April 10th.
AI Summary
On April 10, 2024, Savara Inc. entered into a material definitive agreement. The company also reported the departure of directors or certain officers, the election of directors, and the appointment of certain officers with compensatory arrangements. Additionally, other events occurred that are being reported.
Why It Matters
This filing indicates significant corporate actions, including a new material agreement and changes in leadership, which could impact the company's strategic direction and operational stability.
Risk Assessment
Risk Level: medium — Material definitive agreements and executive changes can introduce uncertainty and potential shifts in strategy, warranting a medium risk assessment.
Key Players & Entities
- Savara Inc. (company) — Registrant
- April 10, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Savara Inc. on April 10, 2024?
The filing states that Savara Inc. entered into a material definitive agreement on April 10, 2024, but the specific details of this agreement are not provided in the excerpt.
Who departed from Savara Inc.'s board or officer positions on or around April 10, 2024?
The filing indicates the departure of directors or certain officers, but does not name the individuals involved in the provided excerpt.
Were new directors elected or officers appointed by Savara Inc. on April 10, 2024?
Yes, the filing reports the election of directors and the appointment of certain officers, along with details on their compensatory arrangements.
What is Savara Inc.'s state of incorporation and IRS number?
Savara Inc. is incorporated in Delaware and has an IRS number of 84-1318182.
What was Savara Inc.'s former name, and when did the name change occur?
Savara Inc. was formerly known as Mast Therapeutics, Inc. and ADVENTRX PHARMACEUTICALS INC, with name changes occurring on March 12, 2013, and June 13, 2003, respectively. It was also formerly known as BIOKEYS PHARMACEUTICALS INC with a name change on September 28, 2001.
Filing Stats: 660 words · 3 min read · ~2 pages · Grade level 11.6 · Accepted 2024-04-12 16:07:55
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share SVRA The Nasdaq Global Se
Filing Documents
- d804195d8k.htm (8-K) — 24KB
- 0001193125-24-094640.txt ( ) — 144KB
- svra-20240410.xsd (EX-101.SCH) — 3KB
- svra-20240410_lab.xml (EX-101.LAB) — 18KB
- svra-20240410_pre.xml (EX-101.PRE) — 11KB
- d804195d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 12, 2024 SAVARA INC. a Delaware corporation By: /s/ Matthew Pauls Matthew Pauls Chief Executive Officer